These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 17583775

  • 1. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, Günaydin I, Kanz L.
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [Abstract] [Full Text] [Related]

  • 2. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA.
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loët X, Sibilia J, Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [Abstract] [Full Text] [Related]

  • 4. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W, Starmans-Kool M, Peeters RM.
    Ned Tijdschr Geneeskd; 2011 Mar; 155(18):A2966. PubMed ID: 21466723
    [Abstract] [Full Text] [Related]

  • 5. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY, Lan JL, Lin FJ, Hsieh TY.
    J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
    [Abstract] [Full Text] [Related]

  • 6. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, Nahm DH, Park HS.
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C, Ridene M, Lequerre T, Costedoat Chalumeau N, Amoura Z, Sellam J, Sibilia J, Bourgeois P, Fautrel B, CRI (Club Rhumatismes et Inflammation).
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [Abstract] [Full Text] [Related]

  • 9. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC.
    Ann Rheum Dis; 2004 Oct; 63(10):1300-6. PubMed ID: 15361391
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
    Nordström D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V, Kajalainen A, Brun JG, Proven A, Ljung L, Kautiainen H, Pettersson T.
    J Rheumatol; 2012 Oct; 39(10):2008-11. PubMed ID: 22859346
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J, Birkenfeld G, Pfirstinger J, Schölmerich J, Fleck M, Brühl H.
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract] [Full Text] [Related]

  • 13. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L, Feist E, Natusch A, Langen S, Krause A, Buttgereit F, Burmester GR.
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH, Kim JJ, Lee JS, Park W, Kim TH, Jun JB, Yoo DH.
    Scand J Rheumatol; 2014 Feb; 43(2):162-9. PubMed ID: 24134323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy.
    Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T.
    Age Ageing; 2007 Jan; 36(1):104-6. PubMed ID: 17158115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Steroid-resistant adult-onset Still's disease which showed a quick response to methotrexate.
    Okamoto O, Oishi M, Fujiwara S.
    J Dermatol; 2008 Feb; 35(2):106-10. PubMed ID: 18271807
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Refractory adult-onset still disease successfully treated with abatacept.
    Ostrowski RA, Tehrani R, Kadanoff R.
    J Clin Rheumatol; 2011 Sep; 17(6):315-7. PubMed ID: 21869709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.